Login / Signup

Case Report: Fecal Microbiota Transplantation for the Treatment of Generalized Eczema Occurring After COVID-19 Vaccination.

Tao HuangYongling LvWei WangYunyao ChenLixin FanZhaowei TengXianfeng ZhouHexiao ShenGuang Fu
Published in: Clinical, cosmetic and investigational dermatology (2024)
Adverse skin reactions caused by the COVID-19 vaccine have attracted considerable attention. As we all know, the development mechanism of some skin diseases is related to the gut and skin microbiome. A 78-year-old male patient who received the COVID-19 vaccine developed generalized eczema with multiple dense black patches over the body, a widespread rash, erosion, and scabs on his limbs, as well as facial edema. The patient experienced recurrent flare-ups after conventional treatment, but then recovered well without recurrence after undergoing three fecal microbial transplantation (FMT) treatments. This rare case is reported for the first time in this study. This report demonstrates the possible potential of FMT in targeting refractory skin diseases, such as eczema, as well as diseases associated with gut microbiota disturbance after vaccination.
Keyphrases
  • case report
  • coronavirus disease
  • sars cov
  • soft tissue
  • rare case
  • wound healing
  • atopic dermatitis
  • cell therapy
  • mesenchymal stem cells
  • human health